Maria Tellez-Plaza1, Domingo Orozco-Beltran, Vicente Gil-Guillen, Salvador Pita-Fernandez, Jorge Navarro-Pérez, Vicente Pallares, Francisco Valls, Antonio Fernandez, Ana María Perez-Navarro, Carlos Sanchis, Alejandro Dominguez-Lucas, Jose M Martin-Moreno, Josep Redon. 1. aINCLIVA Biomedical Research Institute, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain bDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA cDepartment of Preventive Medicine and Public Health, School of Medicine, Universidad Autonoma de Madrid, Madrid dDepartment of Clinical Medicine, University Miguel Hernandez of San Juan de Alicante eUniversity A Coruña, A Coruña fCIBERESP, Instituto de Salud Carlos III, Madrid gDepartment of Medicine, University Jaume I Castellón. Unión de Mutuas de Castellón, Castellón hHealthcare Center of Beniganim, HTA Working Group SEMERGEN, Valencia iEscarval Project, Valencia jHealth Center of Algemesi, Algemesi kDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, Valencia lCIBERObn, Instituto de Salud Carlos III, Madrid, Spain.
Abstract
BACKGROUND: Information about the attributable risk associated with renal dysfunction in patients with cardiovascular risk factors is lacking. OBJECTIVE: We aimed to estimate the attributable risk associated with chronic kidney disease Epidemiology Collaboration-estimated glomerular filtration rate (eGFR), for all-cause mortality, and cardiovascular hospitalization. DESIGN, SETTING, AND PARTICIPANTS: Prospective study of study participants with cardiovascular risk factors in 2008-2012. We included 52 007 cardiovascular disease-free men and women aged 30 years or older with hypertension, diabetes, or dyslipidemia, who underwent routine health examinations in primary care. RESULTS: A total of 6639 (12.8%) patients had eGFR below 60 ml/min per 1.73 m and among them 1782 (3.4%) had 45 ml/min per 1.73 m or lower. During an average follow-up time of 3.2 years, 54.12 deaths, 99.98 coronary heart disease (CHD) hospitalizations, and 90.64 stroke hospitalizations/10 000 person-years were recorded. The population attributable risks associated with having a GFR lower than 60 ml/min per 1.73 m were 6.9% (95% confidence interval = 2.07, 10.65) for all-cause mortality, 6.8% (4.3, 9.4) for CHD hospitalization, and 4.1% (1.02, 7.00) for stroke hospitalization. Participants with increasing number of cardiovascular risk factors displayed increasing population attributable risks associated to a GFR less than 60 ml/min per 1.73 m for all-cause mortality and CHD (P heterogeneity 0.002 and 0.05, respectively). CONCLUSION: In a large general practice cohort of patients with cardiovascular disease risk factors, decreasing eGFR levels were associated with additional attributed risk of mortality and cardiovascular disease. Our findings underscore that intensified efforts are needed to reduce the cardiovascular disease burden associated to chronic kidney disease.
BACKGROUND: Information about the attributable risk associated with renal dysfunction in patients with cardiovascular risk factors is lacking. OBJECTIVE: We aimed to estimate the attributable risk associated with chronic kidney disease Epidemiology Collaboration-estimated glomerular filtration rate (eGFR), for all-cause mortality, and cardiovascular hospitalization. DESIGN, SETTING, AND PARTICIPANTS: Prospective study of study participants with cardiovascular risk factors in 2008-2012. We included 52 007 cardiovascular disease-free men and women aged 30 years or older with hypertension, diabetes, or dyslipidemia, who underwent routine health examinations in primary care. RESULTS: A total of 6639 (12.8%) patients had eGFR below 60 ml/min per 1.73 m and among them 1782 (3.4%) had 45 ml/min per 1.73 m or lower. During an average follow-up time of 3.2 years, 54.12 deaths, 99.98 coronary heart disease (CHD) hospitalizations, and 90.64 stroke hospitalizations/10 000 person-years were recorded. The population attributable risks associated with having a GFR lower than 60 ml/min per 1.73 m were 6.9% (95% confidence interval = 2.07, 10.65) for all-cause mortality, 6.8% (4.3, 9.4) for CHD hospitalization, and 4.1% (1.02, 7.00) for stroke hospitalization. Participants with increasing number of cardiovascular risk factors displayed increasing population attributable risks associated to a GFR less than 60 ml/min per 1.73 m for all-cause mortality and CHD (P heterogeneity 0.002 and 0.05, respectively). CONCLUSION: In a large general practice cohort of patients with cardiovascular disease risk factors, decreasing eGFR levels were associated with additional attributed risk of mortality and cardiovascular disease. Our findings underscore that intensified efforts are needed to reduce the cardiovascular disease burden associated to chronic kidney disease.
Authors: Eugenia Wong; Shoshana H Ballew; Natalie Daya; Junichi Ishigami; Casey M Rebholz; Kunihiro Matsushita; Morgan E Grams; Josef Coresh Journal: Am J Nephrol Date: 2019-07-16 Impact factor: 3.754
Authors: Jorge Navarro-Pérez; Domingo Orozco-Beltran; Vicente Gil-Guillen; Vicente Pallares; Francisco Valls; Antonio Fernandez; Ana María Perez-Navarro; Carlos Sanchis; Alejandro Dominguez-Lucas; Jose M Martin-Moreno; Josep Redon; Maria Tellez-Plaza Journal: BMC Cardiovasc Disord Date: 2018-09-04 Impact factor: 2.298
Authors: Concepción Carratala-Munuera; Adriana Lopez-Pineda; Domingo Orozco-Beltran; Jose A Quesada; Jose L Alfonso-Sanchez; Vicente Pallarés-Carratalá; Cristina Soriano-Maldonado; Jorge Navarro-Perez; Vicente F Gil-Guillen; Jose M Martin-Moreno Journal: Int J Environ Res Public Health Date: 2021-04-12 Impact factor: 3.390